Saif MW. MM-398 Achieves Primary Endpoint of Overall Survival in Phase III Study in Patients with Gemcitabine Refractory Metastatic Pancreatic Cancer. JOP. J Pancreas (Online) [Internet]. 2014 May 27 [cited 2025 Apr. 20];15(3):278-9. Available from: https://serena.sharepress.it/index.php/jop/article/view/2507